REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$13.64 USD
+0.14 (1.04%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $13.50 -0.14 (-1.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -1.29 |
EPS Last Quarter | -1.38 |
Last EPS Surprise | -7.81% |
ABR | 1.08 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.37 |
Next Year | -2.94 |
EPS (TTM) | -5.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.73M | 21.90M | 136.98M | 198.41M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 34.70M | 34.70M | 284.76M | 260.00M |
Low Estimate | 15.00M | 15.00M | 60.62M | 80.62M |
Year ago Sales | 19.98M | 28.91M | 90.24M | 136.98M |
Year over Year Growth Est. | 8.77% | -24.25% | 51.79% | 44.85% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.29 | -1.29 | -4.37 | -2.94 |
# of Estimates | 3 | 3 | 5 | 5 |
Most Recent Consensus | -1.27 | -1.28 | -1.50 | -2.63 |
High Estimate | -1.19 | -1.19 | -1.50 | -1.06 |
Low Estimate | -1.41 | -1.41 | -5.61 | -5.49 |
Year ago EPS | -1.66 | -1.41 | -6.02 | -4.37 |
Year over Year Growth Est. | 22.29% | 8.51% | 27.41% | 32.68% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.29 | -1.29 | -4.37 | -2.94 |
7 Days Ago | -1.29 | -1.29 | -4.37 | -2.94 |
30 Days Ago | -1.29 | -1.29 | -4.37 | -2.94 |
60 Days Ago | -1.26 | -1.25 | -4.51 | -2.44 |
90 Days Ago | -1.25 | -1.23 | -4.46 | -3.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.29 | -1.29 | -4.37 | -2.94 |
Zacks Consensus Estimate | -1.29 | -1.29 | -4.37 | -2.94 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.38 | -1.43 | -1.41 | -1.66 | NA |
Estimate | -1.28 | -1.27 | -1.44 | -1.26 | NA |
Difference | -0.10 | -0.16 | 0.03 | -0.40 | -0.16 |
Surprise | -7.81% | -12.60% | 2.08% | -31.75% | -12.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more